AVIR
Price
$3.37
Change
-$0.10 (-2.88%)
Updated
Aug 29, 03:48 PM (EDT)
Capitalization
275.37M
69 days until earnings call
GALT
Price
$4.25
Change
-$0.01 (-0.24%)
Updated
Aug 29, 03:59 PM (EDT)
Capitalization
272.26M
80 days until earnings call
Interact to see
Advertisement

AVIR vs GALT

Header iconAVIR vs GALT Comparison
Open Charts AVIR vs GALTBanner chart's image
Atea Pharmaceuticals
Price$3.37
Change-$0.10 (-2.88%)
Volume$100
Capitalization275.37M
Galectin Therapeutics
Price$4.25
Change-$0.01 (-0.24%)
Volume$100
Capitalization272.26M
AVIR vs GALT Comparison Chart in %
Loading...
AVIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVIR vs. GALT commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVIR is a Hold and GALT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (AVIR: $3.47 vs. GALT: $4.25)
Brand notoriety: AVIR and GALT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVIR: 61% vs. GALT: 81%
Market capitalization -- AVIR: $275.37M vs. GALT: $272.26M
AVIR [@Biotechnology] is valued at $275.37M. GALT’s [@Biotechnology] market capitalization is $272.26M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVIR’s FA Score shows that 0 FA rating(s) are green whileGALT’s FA Score has 0 green FA rating(s).

  • AVIR’s FA Score: 0 green, 5 red.
  • GALT’s FA Score: 0 green, 5 red.
According to our system of comparison, AVIR is a better buy in the long-term than GALT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVIR’s TA Score shows that 5 TA indicator(s) are bullish while GALT’s TA Score has 3 bullish TA indicator(s).

  • AVIR’s TA Score: 5 bullish, 5 bearish.
  • GALT’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, AVIR is a better buy in the short-term than GALT.

Price Growth

AVIR (@Biotechnology) experienced а -1.70% price change this week, while GALT (@Biotechnology) price change was +9.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.74%. For the same industry, the average monthly price growth was +15.52%, and the average quarterly price growth was +29.97%.

Reported Earning Dates

AVIR is expected to report earnings on Nov 06, 2025.

GALT is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (-0.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVIR($275M) and GALT($272M) have the same market capitalization . GALT YTD gains are higher at: 229.457 vs. AVIR (3.582). GALT has higher annual earnings (EBITDA): -33.52M vs. AVIR (-156.2M). AVIR has more cash in the bank: 380M vs. GALT (13.8M). AVIR has less debt than GALT: AVIR (1.25M) vs GALT (121M). AVIR (0) and GALT (0) have equivalent revenues.
AVIRGALTAVIR / GALT
Capitalization275M272M101%
EBITDA-156.2M-33.52M466%
Gain YTD3.582229.4572%
P/E RatioN/AN/A-
Revenue00-
Total Cash380M13.8M2,754%
Total Debt1.25M121M1%
FUNDAMENTALS RATINGS
AVIR vs GALT: Fundamental Ratings
AVIR
GALT
OUTLOOK RATING
1..100
5985
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
96
Overvalued
PROFIT vs RISK RATING
1..100
9571
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5135
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AVIR's Valuation (36) in the Biotechnology industry is somewhat better than the same rating for GALT (96). This means that AVIR’s stock grew somewhat faster than GALT’s over the last 12 months.

GALT's Profit vs Risk Rating (71) in the Biotechnology industry is in the same range as AVIR (95). This means that GALT’s stock grew similarly to AVIR’s over the last 12 months.

GALT's SMR Rating (100) in the Biotechnology industry is in the same range as AVIR (100). This means that GALT’s stock grew similarly to AVIR’s over the last 12 months.

GALT's Price Growth Rating (35) in the Biotechnology industry is in the same range as AVIR (51). This means that GALT’s stock grew similarly to AVIR’s over the last 12 months.

GALT's P/E Growth Rating (100) in the Biotechnology industry is in the same range as AVIR (100). This means that GALT’s stock grew similarly to AVIR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVIRGALT
RSI
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 8 days ago
79%
Bullish Trend 22 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 17 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
AVIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SIGL0.160.01
+9.59%
Signal Advance, Inc.
LZAGF726.3010.05
+1.40%
Lonza Group AG
SULZF188.79N/A
N/A
Sulzer AG
DRMTY2.20N/A
N/A
DR MARTENS PLC
QTRHF0.78-0.02
-2.47%
Quarterhill Inc.

AVIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVIR has been loosely correlated with AXON. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if AVIR jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVIR
1D Price
Change %
AVIR100%
-3.61%
AXON - AVIR
46%
Loosely correlated
+1.59%
XENE - AVIR
45%
Loosely correlated
-0.69%
ADVM - AVIR
41%
Loosely correlated
-0.33%
NRIX - AVIR
40%
Loosely correlated
-1.47%
IDYA - AVIR
39%
Loosely correlated
-0.28%
More

GALT and

Correlation & Price change

A.I.dvisor indicates that over the last year, GALT has been loosely correlated with BCAB. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if GALT jumps, then BCAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GALT
1D Price
Change %
GALT100%
+6.78%
BCAB - GALT
35%
Loosely correlated
-6.00%
TAOX - GALT
32%
Poorly correlated
-5.42%
RNAC - GALT
32%
Poorly correlated
-3.25%
ERAS - GALT
27%
Poorly correlated
-0.63%
AVIR - GALT
27%
Poorly correlated
-3.61%
More